Evidence map›Paper›PMID 34850351›Full record

ReviewClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2022

Prevention of venous thromboembolism in hematologic neoplasms: an expert consensus from SEHH-SETH.

J R Gonzalez-Porras, J Mateo, V Gonzalez-Calle, P Marco, V Garcia-Gutierrez, J C Reverter, R Lecumberri

Abstract readReviewConsensus Statement
PubMed Publisher
In one paragraph

Review in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

J R Gonzalez-PorrasHematology Department, Hospital Universitario de Salamanca, Instituto Biosanitario de Salamanca (IBSAL), Paseo de San Vicente, s/n, 37007, Salamanca, Spain. jrgp@usal.es.ORCID http://orcid.org/0000-0003-3266-7996
J MateoThrombosis and Hemostasis Unit, Hematology Department, Hospital de La Santa Creu I Sant Pau, Barcelona, Spain.
V Gonzalez-CalleHematology Department, Hospital Universitario de Salamanca, Instituto Biosanitario de Salamanca (IBSAL), Paseo de San Vicente, s/n, 37007, Salamanca, Spain.
P MarcoHematology Department, Instituto de Investigación Sanitaria y Biomedica de Alicante (ISABIAL), Hospital General Universitario de Alicante, Alicante, Spain.
V Garcia-GutierrezHematology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
J C ReverterHematology Department, Hospital Clinic, Barcelona, Spain.
R LecumberriHematology Department, Clínica Universidad de Navarra, IdISNA, CIBERCV, Pamplona, Spain.
Instituto de Investigación Biomédica de Salamanca · ESCentro de Investigación en Red en Enfermedades Cardiovasculares · ESHospital Clínic de Barcelona · ESHospital de Sant Pau · ESHospital General Universitario de Alicante Doctor Balmis · ESInstituto Ramón y Cajal de Investigación Sanitaria · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Venous thromboembolism (VTE) is a serious complication in hematologic neoplasms, so finding adequate prevention strategies is an urgent requirement. However, prospective studies with large enough cohorts are scarce, limiting the development of evidence-based thromboprophylaxis guidelines. The present position paper is addressed to all hematologists treating patients affected by hematologic neoplasms with the aim to provide clinicians with a useful tool for the prevention of VTE.

Indexed as

Hematologic NeoplasmsPulmonary EmbolismVenous ThromboembolismAnticoagulantsHumansProspective StudiesAnticoagulantsDeep-vein thrombosisHematologic neoplasmsPulmonary embolismVenous thrombosis

Identifiers

PMID34850351
OpenAlexW3216580773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.